Renin-Angiotensin System Blockers and the COVID-19 Pandemic: At Present There Is No Evidence to Abandon Renin-Angiotensin System Blockers

A. H.Jan Danser*, Murray Epstein, Daniel Batlle

*Corresponding author for this work

Research output: Contribution to journal › Review article › peer-review

410 Scopus citations

Fingerprint

Dive into the research topics of 'Renin-Angiotensin System Blockers and the COVID-19 Pandemic: At Present There Is No Evidence to Abandon Renin-Angiotensin System Blockers'. Together they form a unique fingerprint.

Keyphrases

Neuroscience

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology